Litigation Details for Novo Nordisk Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2024)
✉ Email this page to a colleague
Novo Nordisk Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2024)
Docket | ⤷ Sign Up | Date Filed | 2024-07-01 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | Assigned To | Colm Felix Connolly | |
Jury Demand | Referred To | ||
Patents | 10,335,462; 8,129,343; 8,536,122 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Novo Nordisk Inc. v. Mylan Pharmaceuticals Inc.
Details for Novo Nordisk Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2024)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2024-07-01 | 1 | Exhibit A - B | U.S. Patent Jul. 2, 2019 Sheet 1 of 6 US 10,335,462 B2 …PageID #: 86 U.S. Patent Jul. 2, 2019 Sheet 3 of 6 US 10,335,462 B2 ….S. Patent Jul. 2, 2019 Sheet 6 of 6 US 10,335,462 B2 … US 10,335,462 B2 Jensen …of 6 US 10,335,462 B2 | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |